About us Contact Terms of Use Data Sources Publications FAQ
RIN3 logo

RIN3

Ras and Rab interactor 3

Expression

StudyTumor samplesMaxQ3Q2Q1MinNormal samplesMaxQ3Q2Q1MinLog2 (T vs N)
Adrenocortical (ACC) 77 2.94 2.24 2.01 1.72 1.06 126 2.20 2.02 1.95 1.88 -0.09 0.06
Bladder (BLCA) 406 2.26 1.81 1.66 1.52 0.85 9 1.89 1.85 1.84 1.67 1.59 -0.18
Breast (BRCA) 1067 2.24 1.67 1.54 1.43 0.99 178 2.08 1.79 1.71 1.63 1.39 -0.16
Cervical (CESC) 297 2.09 1.81 1.68 1.53 0.89 10 1.77 1.74 1.72 1.60 1.40 -0.04
Cholangiocarcinoma (CHOL) 36 2.15 1.84 1.73 1.56 1.17 0
Colon (COAD) 443 2.48 1.89 1.79 1.69 0.83 166 2.33 1.95 1.85 1.78 -0.09 -0.05
B-cell lymphoma (DLBC) 42 2.30 1.88 1.74 1.58 1.17 337 4.25 3.27 3.12 2.96 2.33 -1.38
Esophageal (ESCA) 142 2.10 1.81 1.67 1.56 1.12 271 2.02 1.61 1.54 1.47 -0.09 0.13
Glioblastoma (GBM) 160 2.14 1.82 1.68 1.56 1.19 214 1.44 1.12 0.98 0.88 -0.09 0.70
Head and neck (HNSC) 432 2.13 1.84 1.73 1.58 0.68 55 1.78 1.68 1.56 1.45 1.20 0.16